因苏莱特

204.31
Open
202.93
Market Cap
14.38B+
High
209.35
Low
202.44
Close
204.31
Volume
886.80K+
P/E Ratio
58.71
Div/Yield
0.00%

About 因苏莱特

Insulet Corporation 為胰島素依賴型糖尿病患者開發、製造和銷售胰島素輸送系統。它提供 Omnipod 系統,一種自粘一次性無內胎 Omnipod 設備,一次最多可佩戴三天,以及它的無線伴侶,手持式個人糖尿病管理器。公司主要通過獨立分銷商和藥店渠道銷售其產品,並直接在美國、加拿大、歐洲、中東和澳大利亞銷售。 Insulet Corporation 成立於 2000 年,總部位於馬薩諸塞州阿克頓。

如何購買 因苏莱特 (PODD)

登入
1分鐘開戶

1分鐘開戶

僅需1分鐘即可完成帳戶申請和驗證。整個過程完全自助,支援 RockFlow App 和網頁端操作。

充值資金

充值資金

帳戶驗證完成後,您可以使用首選的支付方式向帳戶充值。

購買 PODD

購買 PODD

透過 RockFlow App 或網頁端搜尋 PODD,輸入您想要投資的金額,然後點擊確認即可完成交易。

logo

Social

Download

google playapp store

© Rockalpha Limited. All Rights Reserved.

Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.